
AstraZeneca has taken its most dramatic steps yet to arrest decline, with chief executive Pascal Soriot axeing two senior positions …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

